Use of Synchronous, Interruptive Electronic Health Record-Embedded Medication Alerts to Improve Evidence-Based Medication Prescribing: Randomized Comparative Effectiveness Trial of Two Prescriber Alerts
In brief
EHR alerts cut inappropriate blood thinner prescribing by 3.5 percentage points
In a large health system, inappropriate apixaban and rivaroxaban prescribing fell immediately by 3.5 percentage points after interruptive electronic health record alerts launched, to 9.7%. About 29% of alerted prescriptions changed within seven days, but adding a pharmacist referral link did not improve that rate; the system-wide drop followed an existing downward trend, so the alerts' longer-term contribution remains uncertain.
- Journal
- Journal of medical Internet research (Q1)
- Published
- 19 November 2026
- Study design
- Randomized controlled trial
- Evidence level
- Level 1, High (CEBM 1b)
- Authors
- Geoffrey Barnes, Seo Youn Choi, Joshua Errickson, F Jacob Seagull, Morris Fabbri, Anish Saraswat, et al.
- PMID
- 43056715
- DOI
- 10.2196/101057
Why clinicians should know about it
- Picked for Family Practice (top studies of the week, 22 November 2026): Ambulatory prescribing alerts target preventable anticoagulant harm
- Picked for Hematology (top studies of the week, 22 November 2026): Randomized trial evaluates alerts correcting inappropriate anticoagulant prescribing
- Picked for Health Informatics (top studies of the week, 22 November 2026): EHR prescribing alerts evaluated for effectiveness and workflow impact
Abstract
BACKGROUND: Antithrombotic stewardship is critical for reducing preventable harm from inappropriate anticoagulant prescribing. Electronic health record (EHR)-embedded clinical decision support (CDS) alerts can prevent prescribing errors at the point of care, but their real-world effectiveness is variable and often limited by alert fatigue and poor workflow integration. Whether augmenting interruptive medication alerts with just‑in‑time access to clinical pharmacists improves prescriber response remains unclear. OBJECTIVE: This study aimed to (1) compare the effectiveness of synchronous, interruptive direct oral anticoagulant (DOAC) prescribing alerts with and without an embedded clinical pharmacist referral option for correcting inappropriate new prescriptions within 7 days, and (2) evaluate the system‑level impact of implementing synchronous DOAC alerts on inappropriate prescribing over time. METHODS: We conducted a prescriber‑level randomized comparative effectiveness trial within a large US academic health system. Prescribers who placed an inappropriate ambulatory apixaban or rivaroxaban order were randomized to receive an interruptive EHR alert either with or without an embedded clinical pharmacist referral link. The primary outcome was any change to the prescription within 7 days. In parallel, a system‑level interrupted time series analysis examined weekly proportions of inappropriate DOAC prescriptions (secondary outcomes) from 24 months before through 29 months after alert implementation. Exploratory outcomes included adverse events within 30 days and alert implementation metrics. RESULTS: Among 2082 prescribers writing DOAC prescriptions during the study period, 300 (14.4%) triggered at least one inappropriate prescription and were randomized; after prespecified exclusions, 758 alerts across 286 prescribers were analyzed. Overall, 28.9% (219/758) of alerts led to a prescription change within 7 days. The proportion of alerts leading to a prescription change did not differ between alerts with and without pharmacist referral (difference 1 percentage point [95% CI -7 to 9]). The system‑wide proportion of inappropriate DOAC prescriptions exhibited a significant downward preimplementation trend (-0.04 percentage points per week [95% CI -0.06 to -0.02]), followed by an immediate 3.5‑percentage‑point absolute reduction at alert launch (to 9.7%), with no subsequent slope change. Adverse events within 30 days were uncommon and similar across arms. CONCLUSIONS: Adding an embedded pharmacist referral option to an interruptive DOAC prescribing alert did not increase short‑term prescription changes. However, the implementation of synchronous, user-centered alerts was associated with a system-level reduction in inappropriate DOAC prescribing. These findings support a complementary digital stewardship model in which high‑value, point‑of‑order alerts prevent routine prescribing errors, while clinical pharmacists focus on complex and longitudinal medication management. TRIAL REGISTRATION: ClinicalTrials.gov NCT05351749; https://clinicaltrials.gov/study/NCT05351749.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.